The Commerce Commission has received a clearance application from GlaxoSmithKline plc seeking clearance to acquire the consumer healthcare business of Pfizer Inc.
GSK is a global pharmaceuticals company active in the research, development, manufacturing and supply of prescription pharmaceuticals, human vaccines, and consumer healthcare pharmaceuticals that are available without a prescription.
Pfizer is also a global pharmaceuticals company involved in the research, development, manufacturing and supply of medicines. Pfizer’s consumer healthcare business develops, manufactures and supplies non-prescription medicines in the areas of pain management, gastrointestinal health, respiratory, dietary supplements and personal care products.
In New Zealand, both parties supply non-prescription cold and flu treatments and medicines for systemic pain relief.
A public version of the clearance application is available on the Commission’s case register.